(New York, NY) – AiCure, an artificial intelligence company providing advanced facial recognition solutions to monitor medication adherence, is pleased to announce the addition of Soeren Mattke, MD, MPH, DSc to its advisory board. Dr. Mattke is a senior scientist at a major policy research institute with expertise in evaluating new technologies and products, and developing innovative approaches to the organization and delivery of health care services, especially for chronic care. He has worked with leading pharmaceutical, device, and health care technology companies and has assisted clients worldwide how best to measure and communicate the value of their innovations. Dr Mattke will be coordinating with AiCure on strategic planning decisions, product approval applications, coverage and reimbursement strategy, post-market product development, and corporate communications. Dr Mattke received his M.D. from the University of Munich and his M.P.H. and D.Sc. from the Harvard School of Public Health.
Adam Hanina, CEO of AiCure, stated that “Dr. Mattke will add extensive knowledge and experience in driving forward AiCure’s mission and market adoption.”